Demant A/s · OMXCOP:DEMANT

Demant A/s — William Demant — Investor Day (2016)

26 slides from Demant A/s's investor day presentation, Dec 31, 2016

  1. Slide 1: Leading in hearing healthcare

    Leading in hearing healthcare Søren Nielsen COO, William Demant

  2. Slide 2: Søren Nielsen

    Søren Nielsen COO (Deputy CEO) of William Demant and President of Oticon Curriculum • Born in 1970 • M.Sc. in Industrial Management and Product Development from the Technical University of Denmark • COO and Deputy CEO since 2015 • Overall responsible for hearing aid wholesale • President of Oticon s

  3. Slide 3: Agenda

    Agenda • The hearing healthcare market • William Demant’s strategy • Position and competition 3

  4. Slide 4: Introducing the hearing healthcare market

    Introducing the hearing healthcare market 4

  5. Slide 5: The hearing healthcare market

    The hearing healthcare market Hearing Devices Hearing Implants Diagnostic Instruments Hearing instruments and Bone-anchored hearing systems Wide range of hearing-related accessories and cochlear implants equipment 5

  6. Slide 6: Hearing devices value chain in commercial market

    Hearing devices value chain in commercial market Manu- End-users/ Suppliers Retailers facturers payers ~5% ~25% ~70% 100% Percentage of value chain • Components • Six main players • Fragmented market • Private market • Consolidated market • Tough competition • Consolidation • Public market • Fight f

  7. Slide 7: Solid structural growth drivers in hearing devices

    Solid structural growth drivers in hearing devices Demography Increasing points of sales Emerging markets • Growing ageing population • Greenfield store openings • Demography • Increasing life expectancy • New channels being tested • Growing penetration rates with a few showing • Improved healthcare

  8. Slide 8: Diagnostic instruments value chain

    Diagnostic instruments value chain Resellers Manu- End-users/ Suppliers and service facturers payers providers ~15% ~55% ~30% 100% Percentage of value chain • Components • Three large players • BtB • Hearing aid dispensers • Critical mass is crucial • SIDs • Hearing clinics etc. • Wide range of prod

  9. Slide 9: Positive growth outlook for diagnostic instruments

    Positive growth outlook for diagnostic instruments New business areas Emerging markets • Balance measurements/diagnostics • Building infrastructure • New-born screening • Improved healthcare systems • eHealth • Higher average income • Increasing life expectancy 9

  10. Slide 10: Hearing implants value chain

    Hearing implants value chain End- Manu- Distri- Clinics / Suppliers users/ facturers butors Hospitals payers ~10% ~55% ~35% 100% Percentage of value chain • Components • Four competitive • Manufacturers in • Hospitals • Reimbursement players most cases • Private clinics • Insurance Note: Surgeon fee

  11. Slide 11: Long-term attractive growth potential in hearing implants

    Long-term attractive growth potential in hearing implants Increasing reimbursement Continuous market expansion New markets • Reimbursement schemes are key • Significant number of new-born • New indications to growing penetration who qualify for a hearing implant • Emerging markets • Increased life e

  12. Slide 12: Attractive value and growth in hearing healthcare

    Attractive value and growth in hearing healthcare Market size (value) Market growth (value) Hearing Devices USD 4bn 1-3% Cochlear Implants USD 1.4bn 10-12% Bone Conduction Systems USD 170m 10-15% Diagnostic Instruments USD 500m 3-5% Hearing Healthcare ~5%* Above number estimates represent wholesale

  13. Slide 13: Attractive value and growth in hearing healthcare

    Attractive value and growth in hearing healthcare • Modest growth in Hearing Devices • Modest growth in Diagnostic Instruments • Strong growth in Hearing Implants Diagnostic 2020 2015 Instruments Diagnostic Instruments Hearing Implants CAGR ~5% Hearing Hearing Implants Hearing Devices Devices Note:

  14. Slide 14: William Demant's strategy

    William Demant’s strategy 14

  15. Slide 15: William Demant's overall vision

    William Demant’s overall vision To make a life- changing difference to people living with hearing loss 15

  16. Slide 16: William Demant's overall strategy

    William Demant’s overall strategy We want to further develop our position as a leading hearing healthcare company with the broadest and deepest product offering based on true innovation – delivered to customers and end-users through a multi-brand approach backed by a comprehensive global distributio

  17. Slide 17: William Demant's value market share

    William Demant’s value market share Hearing aid Diagnostic Bone-anchored Cochlear implants wholesale instruments hearing systems William Demant Other 17

  18. Slide 18: Strategy of delivering profitable long-term growth

    Strategy of delivering profitable long-term growth Hearing Devices Diagnostic Instruments • Maintain technology • Strengthen distribution model leadership • Pursue new market • Multi-brand strategy opportunities • Be present in all channels and • Generate organic and segments acquisitive growth • Ta

  19. Slide 19: Synergies from our hearing healthcare approach

    Synergies from our hearing healthcare approach Distribution • Commercial cross-business synergies • Lead generation across Innovation businesses • Sharing core platform (DSP, • Global distribution platform wireless) • Market insight • Advanced digital signal • Critical mass in local markets processi

  20. Slide 20: Real-life synergies

    Real-life synergies Hearing aid technology in Market access for Oticon Medical Developing state-of-the-art fitting hearing implants through existing customer relations process • Leveraging sound processing from • Existing relationships to ENT doctors • End-user knowledge from retail hearing aids thr

  21. Slide 21: Strong platform for new growth opportunities

    Strong platform for new growth opportunities • Through the strategic focus on innovation, distribution and infrastructure, William Demant has built a strong platform on which to execute on additional future growth opportunities • Diagnostic Instruments and BAHS are both successful additions to Willi

  22. Slide 22: Position and competitive landscape

    Position and competitive landscape 22

  23. Slide 23: We have a strong foundation for growth

    We have a strong foundation for growth Offerings Hearing aid wholesale Cochlear implants Bone-conducting systems Diagnostic instruments Controling distribution = Relative strength in business segment 23

  24. Slide 24: Hearing healthcare trends and strategies

    Hearing healthcare trends and strategies Current trends likely to evolve Strategies supporting long-term profit 1. Product complexity continues to rise 1. Ever growing and innovative R&D organisation 2. Modest value growth due to consolidation in remains king – manufacturers need leverage on retail

  25. Slide 25: William Demant well positioned to win

    William Demant well positioned to win Diversification is key to success • William Demant is able to meet high investment requirements and R&D spend • William Demant is well positioned to benefit from growth in all parts of the hearing healthcare value chain from a broadly based presence • William De

  26. Slide 26: Thank you

    William Demant / Thank you

William Demant — Investor Day (2016) on 6ix